CME-Directory

Chairs: Alexander M. M. Eggermont, MD, PhD, John M. Kirkwood, MD and Anja K. Bosserhoff, PhD Abstract Deadline: 10 July 2006

This course is designed for dermatologists, pathologists, dermatopathologists, head and neck surgeons, primary care practitioners, and other health care professionals with an interest in, and basic understanding of skin cancer. A wide range of experts will participate as this most serious of skin cancers will require our utmost multi-disciplinary efforts to conquer.

Please join us for a CME dinner program on November 5, 2008 in Philadelphia presented by John Kirkwood, MD and Miachael Morse, MD. Learning Objectives: At the conclusion of the program, participants will be able to: 1. Understand the pathophysiology of melanoma. 2. Review current treatments for the different stages of melanoma. 3. Explain the utility of colony-stimulating factor in the management of melanoma. 4. Understand the current clinical data regarding use of colony-stimulating factor in the treatment of melanoma.

Please join us for a CME dinner program on October 14,, 2008 in New York City presented by John Kirkwood, MD and Jedd Wolchok, MD, PhD. Learning Objectives: At the conclusion of the program, participants will be able to: 1. Understand the pathophysiology of melanoma. 2. Review current treatments for the different stages of melanoma. 3. Explain the utility of colony-stimulating factor in the management of melanoma. 4. Understand the current clinical data regarding use of colony-stimulating factor in the treatment of melanoma.

Please join us for a CME dinner program on November 18, 2008 Los Angeles presented by Lynn Spitler, MD and Peter Brett, MD. Learning Objectives: At the conclusion of the program, participants will be able to: 1. Understand the pathophysiology of melanoma. 2. Review current treatments for the different stages of melanoma. 3. Explain the utility of colony-stimulating factor in the management of melanoma. 4. Understand the current clinical data regarding use of colony-stimulating factor in the treatment of melanoma.

Please join us for a CME dinner program on November 19, 2008 in San Francisco presented by Lynn Spitler, MD and Peter Brett, MD. Learning Objectives: At the conclusion of the program, participants will be able to: 1. Understand the pathophysiology of melanoma. 2. Review current treatments for the different stages of melanoma. 3. Explain the utility of colony-stimulating factor in the management of melanoma. 4. Understand the current clinical data regarding use of colony-stimulating factor in the treatment of melanoma.